Chord Therapeutics launches with USD 16 million Series A financing

Backed by Omega Funds to develop new oral treatments for rare autoimmune diseases Financing for clinical trial of lead molecule for the treatment of neuromyelitis optica spectrum disorders GENEVA, Switzerland, Oct. 13, 2020 -- (Healthcare Sales & Mar... Biopharmaceuticals, Venture Capital Chord Therapeutics, cladribine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news